Our latest work : “Upregulation of ALDH1 as an adaptive epigenetic response to anthracyclines in acute myeloid leukemia” has just been published in HemaSphere. This study reveals how ALDH1A1 and…
Read More
© 2025 DECIPHER LABCOM
Marseille, June 2025 – The DECIPHER project, led by Salvatore Spicuglia from TAGC (Inserm) and Mileidys Perez from Advanced BioDesign (ABD), has been selected as one of the 2024 winners…
Read More
Advanced BioDesign unveils ABD0171, a novel ALDH1 inhibitor with potent ALDH1A3 selectivity, showing selective cytotoxicity against aggressive basal-like breast cancers, including TNBC, and other high-need epithelial subtypes. This novel compound…
Read More
Marseille, France – April 8, 2024 – The Theories and Approaches of Genomic Complexity (TAGC) laboratory at Aix-Marseille Université and Advanced BioDesign are proud to announce the successful defense of…
Read More